Dentists in Colby, KS Accepting Medicare
4 Dentists found. Showing 1 - 4
 Scott G. Haas, D.D.S. Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 770 S Range Ave Ste 1, Colby, KS 67701 Phone: 785-460-3922 |
 Dr. Karen Ashely Thummel, DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 480 W 4th St, Colby, KS 67701 Phone: 785-460-6800 |
Dr. Thomas Barlow, DDS Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 505 N Franklin Ave, Colby, KS 67701 Phone: 785-460-7538 |
Dr. Bryan Lee Nagle, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 770 S Range Ave Ste 1, Colby, KS 67701 Phone: 785-460-3922 |
News Archive
Astex earns GBP5.9 M milestone payment from GSK for fragment-based screening platform
Astex Therapeutics, the UK-based biotechnology company developing targeted therapies for oncology and virology, announced that it has achieved multiple early milestones in its fragment-based drug discovery collaboration with GlaxoSmithKline which commenced in November 2009.
RPCI receives ASCO's QOPI certification, Leapfrog Top Hospital recognition
Roswell Park Cancer Institute (RPCI) has again been recognized at the national level for providing high-quality, patient-centered care. One of only three National Cancer Institute-designated comprehensive cancer centers in New York State, RPCI this month received Leapfrog Top Hospital recognition for the second consecutive year and earned Quality Oncology Practice Initiative (QOPI) Certification from the American Society of Clinical Oncology.
North Carolina set to become a leading hub for data-intensive business, data science research
A new collaboration called the National Consortium for Data Science (NCDS) aims to make North Carolina a national hub for data-intensive business and data science research, a move that will help develop a national strategy to ensure U.S. leadership in the data-driven global economy.
Improving drug testing with comprehensive 'Organ Chip' platform
The U.S. Food and Drug Administration approves only 13.8% of all tested drugs, and these numbers are even lower in "orphan" diseases that affect relatively few people.
Drugs blocking the effects of ACh may prevent cancer
By seeing what substances and molecules affect the development of our diseases, we can develop drugs that prevent or cure diseases. In her dissertation at Kalmar University in Sweden, Ann Novotny has found that the signal molecule acetylcholine (ACh) is important for the progress of cancer of the large intestine and colon, knowledge that is important to factor in when developing drugs that block the effects of Ach on tumor cells.
› Verified 9 days ago
Pharmacists
Counselors
Psychologists
Dentists
Clinical Social Workers
Occupational Therapists